Document Detail


Decision-making: stenting in acute myocardial infarction.
MedLine Citation:
PMID:  20462337     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Percutaneous coronary intervention (PCI) plays a pivotal role in the management of patients with acute myocardial infarction (AMI). Rapid revascularization of the patient with evolving AMI results in reduced rates of mortality, reinfarction and greater myocardial salvage with smaller infarct size. Since the performance of the first balloon angioplasty in 1977, remarkable advances have improved the safety and efficacy of PCI. Advances in stent technology and adjunct pharmacology have improved the outcomes for patients with AMI undergoing primary PCI. Drug-eluting stents result in a significant reduction in the clinical and angiographic rates of restenosis. Early concerns of stent thrombosis in the AMI setting have been allayed by recent results from numerous randomized clinical trials and observational studies. Reduced ischemic and hemorrhagic complications from new antithrombin and antiplatelet agents have further reduced mortality and improved event-free survival after primary PCI.
Authors:
Somjot S Brar; Gregg W Stone
Related Documents :
24014387 - Left ventricular contractile reserve in asymptomatic primary mitral regurgitation.
12828227 - The lescol intervention prevention study (lips): start all patients on statins early af...
23666097 - Extracorporeal versus conventional cardiopulmonary resuscitation after ventricular fibr...
23117837 - Selective pde5a inhibition with sildenafil rescues left ventricular dysfunction, inflam...
19054027 - Evaluation of subendocardial and subepicardial left ventricular functions using tissue ...
25007837 - Identification of a circulating microvesicle protein network involved in st-elevation m...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Future cardiology     Volume:  6     ISSN:  1744-8298     ISO Abbreviation:  Future Cardiol     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-05-13     Completed Date:  2010-08-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101239345     Medline TA:  Future Cardiol     Country:  England    
Other Details:
Languages:  eng     Pagination:  301-14     Citation Subset:  IM    
Affiliation:
Regional Cardiac Catheterization Laboratory, 4867 Sunset Blvd, 3rd Floor, Room 3755, Kaiser Permanente Medical Center, Los Angeles, CA 90027, USA. SBrar@cvri.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angioplasty, Transluminal, Percutaneous Coronary
Anticoagulants / therapeutic use
Clinical Trials as Topic
Decision Making
Drug Therapy, Combination
Humans
Medication Adherence
Myocardial Infarction / therapy*
Platelet Aggregation Inhibitors / therapeutic use
Risk Factors
Stents*
Venous Thrombosis / prevention & control
Chemical
Reg. No./Substance:
0/Anticoagulants; 0/Platelet Aggregation Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Point-of-care testing for assessment of adequacy of oral antiplatelet therapy in patients with cardi...
Next Document:  Early therapy following myocardial infarction: arguments for and against implantable cardioverter-de...